Home - Products - Immunology/Inflammation - Antiviral - BTA-188

BTA-188

CAS No. 314062-80-1

BTA-188( —— )

Catalog No. M35989 CAS No. 314062-80-1

BTA-188 is one of the most potent analogues of novel and orally active synthetic benzoxazole and benzothiazole derivatives with significant anti-rhinovirus activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	228	In Stock
5MG	191	In Stock
10MG	259	In Stock
25MG	394	In Stock
50MG	520	In Stock
100MG	684	In Stock
200MG	905	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BTA-188
Note

Research use only, not for human use.
Brief Description

BTA-188 is one of the most potent analogues of novel and orally active synthetic benzoxazole and benzothiazole derivatives with significant anti-rhinovirus activity.
Description

BTA-188 is one of the most potent analogues of novel and orally active synthetic benzoxazole and benzothiazole derivatives with significant anti-rhinovirus activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Immunology/Inflammation
Target

Antiviral
Recptor

Antiviral
Research Area

——
Indication

——

Chemical Information

CAS Number

314062-80-1
Formula Weight

368.47
Molecular Formula

C21H28N4O2
Purity

>98% (HPLC)
Solubility

——
SMILES

C(COC1=CC=C(C=NOCC)C=C1)C2CCN(CC2)C3=CC=C(C)N=N3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Pirodavir

Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds; potent human rhinovirus (HRV) capsid-binding inhibitor.
DDG-39

DDG-39 (1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine) possesses antiviral activity with potent and selective anti-HIV-1 and HBV activity in cell culture. The average antiviral IC50 is 0.61 μM.
Viroxime

Viroxime has antiviral activity and may be used to study coxsackievirus infection in infants.

Sign In Join Free